Gene expression profile of colon cancer cell lines treated with SN-38

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Gene expression profile of colon cancer cell lines treated with SN-38. / Wallin, A; Francis, P; Nilbert, M; Svanvik, J; Sun, Fan.

I: Chemotherapy, Bind 56, Nr. 1, 2010, s. 17-25.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Wallin, A, Francis, P, Nilbert, M, Svanvik, J & Sun, F 2010, 'Gene expression profile of colon cancer cell lines treated with SN-38', Chemotherapy, bind 56, nr. 1, s. 17-25. https://doi.org/10.1159/000287353

APA

Wallin, A., Francis, P., Nilbert, M., Svanvik, J., & Sun, F. (2010). Gene expression profile of colon cancer cell lines treated with SN-38. Chemotherapy, 56(1), 17-25. https://doi.org/10.1159/000287353

Vancouver

Wallin A, Francis P, Nilbert M, Svanvik J, Sun F. Gene expression profile of colon cancer cell lines treated with SN-38. Chemotherapy. 2010;56(1):17-25. https://doi.org/10.1159/000287353

Author

Wallin, A ; Francis, P ; Nilbert, M ; Svanvik, J ; Sun, Fan. / Gene expression profile of colon cancer cell lines treated with SN-38. I: Chemotherapy. 2010 ; Bind 56, Nr. 1. s. 17-25.

Bibtex

@article{3cf2e4c1b5974073b0ce21f19a4f0d25,

title = "Gene expression profile of colon cancer cell lines treated with SN-38",

abstract = "Colorectal cancer is the third most common form of cancer in the industrial countries. Due to advances regarding the treatments, primarily development of improved surgical methods and the ability to make the earlier diagnosis, the mortality has remained constant during the past decades even though the incidence in fact has increased. To improve chemotherapy and enable personalised treatment, the need of biomarkers is of great significance. In this study, we evaluated the gene expression profiles of the colon cancer cell lines treated with SN-38, the active metabolite of topoisomerase-1 inhibitor irinotecan which leads to cell cycle arrest and apoptosis.",

author = "A Wallin and P Francis and M Nilbert and J Svanvik and Fan Sun",

year = "2010",

doi = "http://dx.doi.org/10.1159/000287353",

language = "English",

volume = "56",

pages = "17--25",

journal = "Chemotherapy",

issn = "0009-3157",

publisher = "S Karger AG",

number = "1",

}

RIS

TY - JOUR

T1 - Gene expression profile of colon cancer cell lines treated with SN-38

AU - Wallin, A

AU - Francis, P

AU - Nilbert, M

AU - Svanvik, J

AU - Sun, Fan

PY - 2010

Y1 - 2010

N2 - Colorectal cancer is the third most common form of cancer in the industrial countries. Due to advances regarding the treatments, primarily development of improved surgical methods and the ability to make the earlier diagnosis, the mortality has remained constant during the past decades even though the incidence in fact has increased. To improve chemotherapy and enable personalised treatment, the need of biomarkers is of great significance. In this study, we evaluated the gene expression profiles of the colon cancer cell lines treated with SN-38, the active metabolite of topoisomerase-1 inhibitor irinotecan which leads to cell cycle arrest and apoptosis.

AB - Colorectal cancer is the third most common form of cancer in the industrial countries. Due to advances regarding the treatments, primarily development of improved surgical methods and the ability to make the earlier diagnosis, the mortality has remained constant during the past decades even though the incidence in fact has increased. To improve chemotherapy and enable personalised treatment, the need of biomarkers is of great significance. In this study, we evaluated the gene expression profiles of the colon cancer cell lines treated with SN-38, the active metabolite of topoisomerase-1 inhibitor irinotecan which leads to cell cycle arrest and apoptosis.

U2 - http://dx.doi.org/10.1159/000287353

DO - http://dx.doi.org/10.1159/000287353

M3 - Journal article

VL - 56

SP - 17

EP - 25

JO - Chemotherapy

JF - Chemotherapy

SN - 0009-3157

IS - 1

ER -

ID: 34374597